Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers
EZH2 抑制剂 Tulmimetostat 的全面靶向作用可靶向治疗 ARID1A 突变癌症
期刊:Cancer Research
影响因子:12.5
doi:10.1158/0008-5472.CAN-24-0398
Patricia J Keller #, Elizabeth J Adams #, Rentian Wu #, Alexandre Côté, Shilpi Arora, Nico Cantone, Rosana Meyer, Jennifer A Mertz, Victor Gehling, Jike Cui, Jacob I Stuckey, Avinash Khanna, Feng Zhao, Zehua Chen, Ziyang Yu, Richard T Cummings, Mohammed Taimi, Nehal J Lakhani, Drew Rasco, Martin Gut